News
Quantum Genomics nominated for the Galien MedStartUp Award for the innovative design of its NEW-HOPE trial
Press Release
Paris & New York, 16 October 2017
Quantum Genomics nominated for the Galien MedStartUp Award for the innovative design of its NEW-HOPE trial
Quantum Genomics....
3 Marijuana Stocks That Like to Live Life Dangerously
In case you haven't noticed, marijuana stocks are absolutely on fire. Many of the largest pot stocks by market cap have seen their valuations double, triple, or perhaps head even higher over the....
Why Ardelyx Inc Skyrocketed Higher Today
Ardelyx (NASDAQ: ARDX) stock rose 44% on Thursday after the company announced positive data from the phase 3 T3MPO-2 trial testing its irritable bowel syndrome drug, tenapanor, after the close of....
Why AcelRx Pharmaceuticals Inc Got Cut in Half Today
AcelRx Pharmaceuticals (NASDAQ: ACRX) is down 57% at 12:41 p.m. EDT after the Food and Drug Administration rejected the company's pain medication Dsuvia. As I said earlier this month when the....
Here's Why Abeona Therapeutics Inc. Stock Spiked Today
Shares of Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biotech developing novel gene therapies to treat rare genetic disorders, popped as much as 14% higher on Wednesday morning after....
Here's Why AnaptysBio Inc. Is Rocketing Higher Today
Shares of AnaptysBio Inc. (NASDAQ: ANAB), a clinical-stage biotech developing novel anti-inflammatory drugs, took flight after the company reported positive data from a clinical trial with its....
Why the Bears Are Wrong About Keryx Biopharmaceuticals Stock
I haven't exactly been a bull when it comes to Keryx Biopharmaceuticals (NASDAQ: KERX). For starters, it's not even a biotech company (trying for the old "bait-and-switch" move, eh?). It doesn't....
3 Stocks That Could Lose You a Lot of Money
Even the most successful investors swing and miss from time to time. It's a big, messy world out there, and no one has all the information they need to scout out only winning stocks for their....
Where Will Cara Therapeutics Be in 5 Years?
Cara Therapeutics (NASDAQ: CARA) has been one of the most exciting biotech stocks to watch in 2017, and the excitement has stemmed from both positive and negative developments. By late June, the....
Why ImmunoGen, Inc. Dropped Today
Shares of ImmunoGen (NASDAQ: IMGN) are down 11% at 3:29 p.m. EDT after announcing yesterday that it plans to sell 13 million shares through a secondary offering. Investors could be further diluted....
Big Day on Deck for Flexion Therapeutics
Flexion Therapeutics (NASDAQ: FLXN) is about to find out if its research efforts will pay off. The U.S. Food and Drug Administration is expected to issue a go/no-go decision on its treatment for....
BOIRON : Formulaire de déclaration mensuelle des droits de vote au 30 septembre 2017
Le 5 octobre 2017
Publication
du nombre d'actions composant le capital et du nombre total de droits de vote
(articles L. 233-8 II du code de commerce et 223-16 du règlement général de....
Why Shopify, Momenta Pharmaceuticals, and MBIA Slumped Today
The stock market saw new highs on Wednesday, even though gains for most major benchmarks were extremely small. Investors are trying to balance their enthusiasm about the U.S. economy and potential....
Here's Why Rigel Pharmaceuticals, Inc. Reversed Course Today
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) got off to a rocky start this morning, falling more than 8% before the market digested the details of a recently announced share offering. The....
Here's Why Strongbridge Biopharma Fell as Much as 20% Today
Shares of Strongbridge Biopharma (NASDAQ: SBBP) dropped 20% this morning after the rare-disease therapeutic developer announced the pricing of a share offering. The company will sell 4 million....
Here's Why NewLink Genetics Corp. Stock Is Surging Again Today
Shares of NewLink Genetics Corp. (NASDAQ: NLNK), a clinical stage biotech with an oncology focus, are rising in response to a secondary offering that ended up priced much better than anticipated.....
Like a Weed, This Marijuana Stock Catapulted Higher by 34% Last Week
If you're an investor, chances are you're well aware that it's been tough to surpass the returns from marijuana stocks over the past year. In late June, the average trailing 12-month return of the....
3 Top Small-Cap Stocks to Buy in October
Even though Halloween is coming, don't let all small-cap stocks scare you. While it's generally true that smaller businesses present higher risks to investors than larger companies do, they may....
Quantum Genomics Releases 2017 First-Half Financial Results and First Nine Months Business Update
Paris & New York, October 3, 2017
Positive results from Phase IIa trial of QGC001 for the treatment of arterial hypertension
Launch of NEW-HOPE Phase II targeted clinical trial in the....
Quantum Genomics publie ses résultats financiers semestriels et fait le point sur l'activité des 9 premiers mois de l'année
Paris, le 3 octobre 2017
Résultats positifs de l'étude de phase IIa avec QGC001 dans l'hypertension artérielle
Lancement de NEW-HOPE, essai clinique ciblé de phase II aux....
Intercept Pharmaceuticals, Inc. Was Halved in September, but Presents an Intriguing Opportunity
Shares of Intercept Pharmaceuticals (NASDAQ: ICPT), a small-cap biotech company with a focus on discovering medicines to treat non-viral, progressive liver diseases, lost roughly half of its value....
Why AcelRx Pharmaceuticals Inc Jumped Higher Today
AcelRx Pharmaceuticals (NASDAQ: ACRX) closed up nearly 20% on Monday, having jumped a whopping 64% over the last week. While there's no apparent news today to drive the stock higher -- or within....
Here's Why Rigel Pharmaceuticals, Inc. Is Jumping Higher Today
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a clinical-stage biotech, are on the rise today after the company announced results of a recent meeting with the Food and Drug Administration.....
Why Seres Therapeutics Inc. Stock Is Tanking Today
Shares of Seres Therapeutics (NASDAQ: MCRB), a clinical-stage biotech focused on microbiome therapeutics, were down 19% as of 11:25 a.m. EDT on Monday. The decline can be traced to the release of....
Why Dynavax Technologies Corporation Stock Is Rising Today
Shares of Dynavax Technologies Corporation (NASDAQ: DVAX) are up by over 11% in pre-market trading on modest volume this morning, following a report that management is exploring different....